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responsibility of XAbstract A rapid and simple method for the determination of polyhexamethylene biguanide
(polyhexanide, PHMB) in liquid and gel-like pharmaceutical formulations by means of high
performance liquid chromatography coupled to diode-array detection (HPLC–DAD) was devel-
oped. Best separation was achieved using a cyanopropyl bonded phase (Agilent Zorbax Eclipse
XDB-CN column 4.6 mm 75 mm with particle size of 3.5 mm) as well as gradient elution
consisting of acetonitrile/deionized water at a ﬂow rate of 1.0 mL/min. The optimized and applied
chromatographic conditions permitted separation of polyhexanide from interacting matrix with
subsequent detection at a wavelength of 235 nm with good sensitivity. The method validation was
carried out with regard to the guidelines for analytical procedures demanded by the International
Conference on Harmonisation (ICH). Mean recoveries of 102% and 101% for gel-like as well as
liquid preparations were obtained. Suitable repeatability as well as intermediate precision could be
achieved with limits of detection r0.004 mg/mL for both formulations, equivalent to r0.004%
PHMB concerning sample preparation. Determination of PHMB was accomplished without
tedious sample preparation. Interacting matrix could be eliminated by the chromatographicersity. Production and hosting by Elsevier B.V. All rights reserved.
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Fig. 1 Chemical structure of PH
groups.
Determination of polyhexamethylene biguanide in pharmaceuticals by HPLC–DAD 409procedure with excellent performance of system suitability. All analytical requirements were
fulﬁlled permitting a reliable and precise determination of PHMB in pharmaceuticals. Further-
more, the developed method was applied to stability testing of pharmaceutical preparations
containing PHMB.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Polyhexamethylene biguanide hydrochloride (Polyhexanide,
PHMB) is a chemical biocide. Therefore, it is used as an active
ingredient in a lot of products such as wet wipes, wound
irrigation solutions, sterile dressings as well as disinfectants.
Due to its excellent properties the usage increased for application
to personal care products and pharmaceuticals in wound
management, for instance treatment of chronic wounds and
burns [1]. This widely used biocide has been reviewed by US
Environmental Protection Agency (EPA) and noted, with the
exception of occupational users, as having very low aggregate
risk of adverse health effects to the public or environment [2].
PHMB binds to the negatively charged phosphate head
groups of phospholipids at bacteria cell wall, causing increased
rigidity, sinking nonpolar segments into hydrophobic
domains, disrupting the membrane with subsequent cytoplas-
mic shedding culminating in cell death [3]. The antibacterial
activity of PHMB depends on the molecular structure. Mini-
mum requirements are met by more than 2 biguanide moieties
and 5–7 methylene groups as a spacer. Therefore, PHMB
represents an oligomeric substance with number-average
degree of polymerization of 2–5 [3]. The chemical structure
of PHMB is shown in Fig. 1. It is a cationic biocide marketed
worldwide, because of its excellent antimicrobial activity,
chemical stability, low toxicity and reasonable cost [4]. PHMB
is highly soluble in water (20%, w/v) and aliphatic alcohols
but poorly soluble in nonpolar liquids. The biguanide moieties
are strong bases and monoprotonated at a pH value of 7
(pKa1¼2–3; pKa2¼10.5–11.5) resulting in a polycation with
a positive charge at each biguanide moiety [3].
With regard to its application in surgical dressing the need
of pharmaceutical preparations containing PHMB on the
basis of liquid and gel-like dosage forms increased clearly
over the last years in our hospital. Therefore, products from
our own manufacture were established for application to our
hospital’s wards requiring examinations in quality control to
ensure the pharmaceutical drug safety. Hence, beside physico-
chemical speciﬁcations, quantiﬁcation of the PHMB content is
essential. For those liquid and gel-like preparations of PHMB
a sensitive and speciﬁc method of determination should be
used. Several methods for analyzing PHMB in chemical
disinfectants, eye drops or further personal care products areMB and possible terminaldescribed in literature [5–12]. Chromatographic applications
like liquid chromatography or capillary electrophoresis as well
as titrimetric methods were used. Most applications exhibited
high limits of detection (LOD) insufﬁcient for the referred
applications. In addition, PHMB only shows applicable UV
absorption at 235 nm attributed to the p–pn transition of
–CQN– in the biguanide group [4,13] that was used in
determination of PHMB in disinfectants by high performance
liquid chromatography coupled to diode-array detection
(HPLC–DAD) but a high LOD was also observed. Never-
theless, all described methods in literature report on the
determination of PHMB in non-pharmaceutical formulations
(medical devices as well as personal care products). However,
there are no reports of HPLC methods in literature that were
developed and validated for the analysis of pharmaceutical
formulations as well as stability testing. Moreover, as reported
by Al-Rimawi et al. [14], methods of Pharmacopeia for raw
material analysis sometimes provide procedures which either
do not include pharmaceutical formulations or cannot be
applied to them due to missing selectivity concerning degrada-
tion products and interfering excipients present in the phar-
maceutical dosage forms. In terms of polyhexanide, only one
monograph (namely polihexanide solution 20% used as a raw
material for drug manufacturing as well as extemporaneous
products) is listed using a gravimetric analysis which
is unsuitable for the speciﬁc analysis of polyhexanide in
pharmaceutical formulations.
Thus, the aim of this study was to develop and implement
an analytical procedure for PHMB in liquid and gel-like
dosage forms with the required sensitivity and speciﬁcity for
quality control in drug manufacturing. Typical concentrations
of PHMB in those formulations are 0.04% (w/w). Liquid
chromatography coupled to diode-array detection should be
used as a commonly applied system. The guidelines of the
International Conference on Harmonisation (ICH) were
adopted for method validation [15]. In order to implement
an efﬁcient, economic and simple analytical procedure both
sample preparation and analysis should be accomplished in
one step separating matrix compounds and quantifying the
analyte.
This paper presents a rapid, simple and stability-indicating
method based on HPLC–DAD that was developed for the
separation and quantiﬁcation of PHMB in liquid and gel-like
pharmaceutical dosage forms without tedious sample prepara-
tion for the ﬁrst time.2. Experimental
2.1. Chemicals and reagents
HPLC-grade water (deionized water) was obtained by purify-
ing demineralized water in a Milli-Q system (Millipore,
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chased from Sigma Aldrich (Weinheim, Germany). PHMB
reference substance (200 mg/mL; certiﬁed regarding the
requirements of DAC (German Pharmaceutical Codex) for
impurities [16]) was bought from B. Braun Melsungen AG
(Melsungen, Germany). The stock standard solution of
PHMB (1 mg/mL) and further dilutions were prepared with
HPLC-grade water.
The quantitative composition of used products manufac-
tured in the hospital’s preparation department was as follows.
PHMB wound irrigation solution (liquid matrix) contains 0.04 g
PHMB, 0.86 g sodium chloride, 0.033 g calcium chloride, 0.03 g
potassium chloride as well as puriﬁed water added to 100 g.
PHMB wound gel (gel-like matrix) contains 0.04 g PHMB,
6 g hydroxyethyl cellulose 400 as well as water for injection
added to 100 g.
After drug ﬁlling both preparations are sterilized subse-
quently (autoclaving at 2 bar and 121 1C for 30 min).2.2. Instrumentation
The LC system consisted of an Agilent 1100 HPLC system
equipped with degasser and autosampler, coupled to a diode-
array detector set at 235 nm (bandwidth 5 nm; reference
360 nm, bandwidth 50 nm) (Agilent Technologies, Wald-
bronn, Germany). The injection volume was set to 100 mL
and the separation was carried out on an Agilent Zorbax
Eclipse XDB-CN (4.6 mm 75 mm) with particle size of
3.5 mm and guard column (4.6 mm 12.5 mm). The mobile
phase was composed of deionized water (solvent A) and
acetonitrile (solvent B). The column temperature was kept at
20 1C and controlled by an oven. A constant ﬂow rate of
1.0 mL/min was applied throughout the analysis.
For liquid and gel-like samples two different chromato-
graphic conditions were chosen.
The following LC gradient was used for the separation of
liquid preparations: isocratic from 0 to 1 min (95% A/5% B);
from 1 to 7 min a linear increase of B to 50% that was held for
further 3 min. Initial conditions were re-established immedi-
ately and the column equilibrated for 5 min.
For gel-like preparations the separation was obtained with
isocratic elution for 1 min (95% A/5% B) followed by
subsequent linear increase of B to 40% within 9 min. Initial
conditions were re-established immediately with an equilibra-
tion time of 5 min.2.3. Sample preparation
2.5 g of each matrix (gel-like or liquid formulation) was
weighted into a 25 mL volumetric ﬂask. For evaluating the
recovery blank matrices were used and required volumes of
standard solution were added at this point to obtain spiked
samples at levels of 60%, 100% as well as 140% of the active
ingredient. The volumetric ﬂask was ﬁlled up with deionized
water and homogenized by vigorous shaking. 1.5 mL of the
sample solution was ﬁlled into a screw-capped vial and analyzed
by high performance liquid chromatography with diode-array
detection. Five calibration standards with concentrations of
0.02–0.06 mg/mL were prepared similarly in deionized water.
Blank solutions of each matrix were analyzed as well.2.4. Validation study
The method was validated considering the guidelines of ICH
by determining speciﬁcity, linearity and range, precision
(repeatability and intermediate precision), accuracy and
robustness [15]. Evaluation of limits of detection (LOD) and
quantitation (LOQ) is not part of ICH for methods determin-
ing the content or potency but these were ascertained within
the validation study.
Furthermore, the stability of standard and sample solutions
was investigated as a function of storage time over the period
of validation as proposed by ICH.
The developed method should fulﬁll the following require-
ments as speciﬁcation of performance.
Speciﬁcity: the UV-spectra of PHMB in samples may differ
up to 5% from library UV-spectra.
Accuracy: the results should be within the range of 95–
105%, tested with 3 concentration levels covering the speciﬁed
range.
Precision: repeatability and intermediate precision are to
result in less than 75% in relation to the content of PHMB
(0.0470.002 mg/mL).
Linearity and range: the linear relationship should be
achieved across the range of 60–140% in relation to the
content of PHMB with a correlation coefﬁcient R2Z0.995.
Moreover, system suitability tests according to the
Reviewer Guidance of the Center for Drug Evaluation and
Research (CDER) [17] were carried out to establish a reliable
chromatographic system. These tests were determined by
injecting sample solutions of each matrix (consisting of
0.04 mg/mL PHMB) six times. From this data set system
suitability speciﬁcations such as repeatability of retention time
and analyte peak area, theoretical plates as well as asymmetry
(tailing factor; Tf) were calculated.2.5. Stability assessment
For the evaluation of stability several forced degradation
procedures were carried out with separately prepared PHMB
solutions 0.04%. Degradation was initiated by dissolving
100 mg of PHMB solution (20%) in 50 mL of the respective
buffer solution or 3% hydrogen peroxide solution as outlined
below. The solutions were equilibrated to 50 1C and samples
of the reaction solutions (1 mL) were analyzed daily in order
to determine degree of degradation. All studies were obtained
using the developed and validated chromatographic method.
Hydrolysis study was performed with pH 3 (acetate buffer
solution), 7 and 10 (phosphate buffer solution) at 50 1C within
7 days. Oxidative degradation was initiated by 3% hydrogen
peroxide solution for 7 days at 50 1C. Furthermore, inﬂuence
of heat was investigated due to the sterilization process during
the manufacturing of PHMB wound irrigation solution and
PHMB wound gel at 121 1C (2 bar) for 30 min. Susceptibility
to light was not performed due to storage with light protection
(cardboard box) and known photostability [16,18]. Moreover,
PHMB shows no absorbance above 260 nm [4]. For testing the
long-term stability 3 batches were analyzed at intervals of 3
months over a period of more than 12 months. These batches
were stored at 2572 1C; 60%75% relative humidity in their
marketing packs. Physical properties like appearance, clarity
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attributes.3. Results and discussion
3.1. Optimization of the chromatographic conditions
Optimization of the method was started with selection of the
analytical column. Due to the highly polar character of
PHMB several analytical columns of different suppliers using
nonpolar as well as more polar bonded phases such as
cyanopropyl were examined. The use of reversed phases
(C8 and C18, respectively) resulted in both poor separation
of PHMB and matrix compounds and asymmetry of analyte’s
peak. Best performance could be achieved using cyano bonded
phases such as Zorbax Eclipse XDB-CN. Excellent separation
and peak symmetry were obtained. These ﬁndings were
veriﬁed by analyses of degraded samples resulting in good
resolution (RsZ1.5).
Furthermore, observed matrix interactions during chroma-
tography could be minimized using the optimized chromato-
graphic conditions. With regard to the different matrices two
chromatographic methods had to be used in order to obtain
efﬁcient separation. Gelling agent from gel-like matrix inter-
fered with PHMB during chromatography when the content
of acetonitrile increased excessively. Therefore, using moder-
ate elution conditions this inﬂuence could be prevented.
Representative chromatograms of samples are shown in
Fig. 2. The peak eluted with retention time at approximatelyTable 1 Repeatability of retention time and area, calculated th
suitability tests (SST) for the developed method as recommended
Matrix Retention time
(min)
Repeatability
(retention time)
(RSD %)
R
(R
Gel-like 5.588 0.01
Liquid 4.937 0.06
Criteria – o5 o
The SST was carried out by injecting one sample per matrix (0.04 mg/m
Fig. 2 Chromatograms of polyhexanide wound gel (A, gel-like matri
1¼standard; 2¼sample; 3¼blank sample. The concentration amount0.7 min was expected to be macrogol 4000, an excipient in
polyhexanide concentrate which is used for manufacturing.
This result agrees with occurrence in chromatograms of
sample and blank but not in standard.
The chromatographic conditions were evaluated and opti-
mized regarding theoretical plates, asymmetry and repeatabil-
ity of retention time as demanded by CDER [17]. The results
of this system suitability evaluation (system suitability test;
SST) are shown in Table 1.
3.2. Sample preparation
Due to chromatographic conditions interfering matrix could
be separated. Thus, particular sample preparation was not
required. To achieve suitable sample solutions gel-like for-
mulations had to be diluted tenfold with deionized water. In
order to obtain both comparable sample preparation proce-
dure and use of single calibration liquid samples were
prepared similarly. Typical chromatograms of liquid and gel-
like dosage forms are shown in Fig. 2.
As ﬁltration is often recommended in pharmaceutical
analyses this approach was studied using common polyester
membrane ﬁlters with 0.45 mm pore size (Macherey & Nagel,
Du¨ren, Germany). As a result, no adsorption of PHMB could
be observed enabling ﬁltration if necessary.
3.3. Method validation and performance
The validation of the proposed method was based on the ICH
guideline for validation of analytical procedures [15]. Hence,eoretical plates as well as asymmetry obtained from system
by CDER [17].
epeatability (area)
SD %)
Theoretical
plates
Asymmetry
(Tf)
0.05 8229 1.3
0.05 6963 1.6
5 42000 o2
L) six times and repeated every week during the validation study.
x) and polyhexanide wound irrigation solution (B, liquid matrix).
s to 0.04 mg/mL PHMB for standard and sample.
Table 2 Accuracy and precision data, LOD and LOQ for polyhexamethylene biguanide as results of validation study considering
the ICH guideline for validation of analytical procedures [15].
Matrix Concentration levela
(mg/mL)
Recovery (Accuracy) (%) Intermediate precision (%) Repeatability (%) LODa
(mg/mL)
LOQa
(mg/mL)
Gel-likeb 0.02 102.7 6.3 5.0 0.004 0.013
0.04 102.2 5.2 2.9
0.06 101.2 2.1 1.7
Liquidc 0.02 101.1 4.9 5.3 0.001 0.003
0.04 100.7 0.5 0.5
0.06 100.3 0.7 0.6
a(mg/mL) correspond to (%) PHMB concerning sample preparation.
bNumber of samples per level n¼12 (analyzed in triplicate).
cNumber of samples per level n¼9 (analyzed in triplicate).
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sion, robustness as well as stability of standard and sample
solutions were investigated in terms of parameters to be
considered within the validation study. The results are shown
in Table 2.
3.3.1. Speciﬁcity
Speciﬁcity was accomplished using UV-spectra obtained from
diode-array detector by comparing the chromatograms of
liquid and gel-like formulations obtained for spiked as well
as blank samples. Peak purity was calculated by means of
HPLC software (ChemStation; Agilent, Waldbronn) for these
spectra and compared to spectra library. No interactions
could be observed resulting in similarity factors 4995 in
either case. Therefore, we conclude that this method is
selective and suitable for the identiﬁcation and quantiﬁcation
of PHMB in the different tested pharmaceutical formulations.
3.3.2. Linearity, LOD and LOQ
The linearity was studied by analyzing standard solutions with
each analysis in triplicate at ﬁve concentration levels in the
range of 0.02–0.06 mg/mL (60–140% of PHMB equivalent to
0.02–0.06% PHMB considering sample preparation). The
correlation coefﬁcient (R2) was found to be 0.999 in general.
The respective linear regression equations for liquid and
gel-like matrices were found to be y¼867.91xþ0.37 and
y¼859.73xþ0.29, respectively.
The LOD and LOQ for each matrix were determined from
signal-to-noise ratios (S/N) of 3:1 and 10:1 by injecting
calibration solutions. The LOQ was veriﬁed by analysis of
spiked samples deﬁned as a minimum precision o30% at this
level. The conﬁrmation of comparable LOD and LOQ in both
calibration standard and sample underscores the excellent
separation of matrix and permits the precise determination
of PHMB over the linearity range. Nevertheless, in the case of
gel-like matrix an increased LOD and LOQ was detected as a
result of matrix inﬂuence increasing noise.
3.3.3. Accuracy and precision
Accuracy was established by recoveries at three concentration
levels achieving excellent precisions and recoveries for both
matrices. For calculation of recoveries as well as repeatability
and intermediate precision three samples of each matrix per
day as well as concentration level (repeated in triplicate) were
analyzed and this procedure was carried out at further days(four and three times regarding gel-like and liquid prepara-
tions, respectively). In particular for gel-like samples, recov-
eries of more than 100% were observed. The inﬂuence of the
matrix was ascertained as the probable cause of these results
as such effects could not be detected in liquid preparations.
3.3.4. Robustness
Assessment of robustness was investigated by system suitabil-
ity tests and varying the ﬂow rate (70.1–0.2 mL/min), column
oven temperature (71–2 1C) and proportion of acetonitrile in
the mobile phase (70.5–1%). Inﬂuence on robustness was
only observed with variations in content of acetonitrile
resulting in poor peak shape and insufﬁcient resolution (due
to decreasing theoretical plates) whereas other parameters did
not change appreciably. Furthermore, the observed intermedi-
ate precision proved a robust procedure.
3.3.5. Stability of standard and sample solutions
The stability of PHMB standard and sample solutions was
investigated as short-term stability. For that purpose, calibra-
tion and sample solutions were stored at temperatures of 2–
8 1C as well as ambient temperature (20 1C) for approximately
6 weeks (period of validation study). Results of 8 calibrations
in repeated measurement during this period were achieved and
calculated as overall slope with relative standard deviation.
No signiﬁcant degradation of PHMB (with relative standard
deviation of overall slope o0.6%) was observed compared to
results obtained for the corresponding daily prepared solu-
tions. Similar results were observed for sample solutions.
This result emphasizes both the stability of PHMB under
the selected storage conditions and the applicability of the
method to routine analyses.
Summarized, the results for system suitability tests (shown
in Table 1) as well as validation study (shown in Table 2)
demonstrate a reliable, robust and precise procedure for the
determination of PHMB using the proposed method fulﬁlling
all performance speciﬁcations.
3.4. Application to real samples and stability assessment
The developed procedure was applied to the analysis of real
samples from the manufacturing. All validation parameters
could be conﬁrmed and the method was proved to be suitable
for routine analysis regarding both rapid and accurate results.
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ture (2572 1C; 60%75% relative humidity) within more than
12 months after manufacturing as long-term stability testing
were analyzed as well. As a result, neither signiﬁcant decrease of
the active substance PHMB (o1%; 3 batches; speciﬁcation for
compliance: o2.5%) nor other variations could be observed.
These data are consistent with literature and ascertain the
excellent stability of PHMB in preparations [4,16].
For pharmaceutical analysis stability indicating methods
are important to investigate and consider the stability of the
preparation in many cases, especially concerning speciﬁcation
of expiration date as well as storage conditions.
Therefore, the investigation of degradation products is very
important. For instance, these could be generated by hydro-
lysis under tightened storage conditions.
For the evidence of a stability indicating performance of the
used analytical procedure several stress tests were accom-
plished. These included susceptibility to pH value, temperature
and oxidation in accordance with the intended storage condi-
tions as well as manufacturing process.
With both acidic and alkaline conditions degradation of
PHMB (5.2% and 9.4%) could be observed while temperature
caused no degradation. Best stability was observed for pH values
of 5–7. As a result of manufacturing development the pH range
of both wound irrigation solution and wound gel was deﬁned to
be in a range of 5.5–6.5 as a speciﬁcation parameter.
Oxidative conditions induced moderate degradation of
PHMB (o5%). Typical chromatograms obtained following
the assay of stressed samples are shown in Fig. 3.
In either case peak purity was controlled by HPLC software
during chromatography and resulted in similarity factors 4990
demonstrating suitable resolution of the chromatographic system
regarding occurring degradation products. Calculated resolutions
of PHMB and closest eluting peaks were Z1.5.
In addition, by the usage of reference substances obtained
from several suppliers remarkable results were observed
during validation study that related to the kind of PHMBFig. 3 Representative chromatograms of polyhexanide (0.04%) on t
Peaks exhibiting spectra comparable with PHMB are marked by a
described for gel-like matrix. Using chromatographic conditions of liq
shape were observed except for shortened retention times.chemical synthesis. PHMB can be synthesized by different
routes resulting in various degree of polymerization depending
on the manufacturer [3,4]. The reference substance used for
the method validation produced a single peak during chro-
matography while another one was separated into a multitude
of peaks as shown in Fig. 4. This result seems to be a further
clear proof for the suitability of the chromatographic method
for stability testing assays enabling measurement of degrada-
tion products of PHMB. The UV-spectra of observed peaks
were comparable to the reference spectra of PHMB demon-
strating similar moieties. Similar results could be observed for
degradation by acidic and alkaline conditions. This implicates
hydrolysis of the biguanide moiety resulting in PHMB
shortened for some monomer units. Under oxidative condi-
tions two peaks eluting close to PHMB (4.7 min and 5.1 min)
also showed similar reference spectra with the exception of the
large peak eluting at 2.7 min. Peaks exhibiting spectra com-
parable with PHMB are marked by asterisks in Fig. 3.
For this reason, a stability indicating power of the used
analytical procedure can be assumed.
Summarized, PHMB could be considered to be very stable
in terms of thermal stress. Under strong acidic as well as
alkaline conditions moderate degradation was observed
whereas best stability was achieved at pH 6. PHMB was also
proved to be fairly resistant to oxidative stress conditions.4. Conclusions
Separation of hydrophilic and ionic compounds like PHMB
can be achieved by usage of polar and special prepared cyano
bonded phases such as Zorbax Eclipse XDB-CN. Due to the
selection as well as optimization of chromatographic condi-
tions both rapid and simple sample preparations as well as
excellent system suitability were obtained. Moreover, the
interfering matrix of samples could be separated from PHMB
permitting a reliable and precise determination. As a result, anhermal (1), acidic (2), alkaline (3) and oxidative (4) degradations.
sterisks. Applied chromatographic conditions were the same as
uid matrix no signiﬁcant differences concerning resolution or peak
Fig. 4 Chromatograms of standard solutions at high (1) and low (2) content of oligomeric composition. Possible oligomers of PHMB
were termed as ‘‘O’’. These unknown compounds were characterized by UV-spectra, which corresponded to PHMB with high correlation
indicating similar moieties. Chromatogram (1) was enlarged threefold. The concentration of PHMB represented 0.04 mg/mL in each
solution. The UV-spectra of peaks in the area from 0 to 3.5 min were unspeciﬁc and not characterized closer.
M. Ku¨sters et al.414accurate, precise and robust analytical procedure was devel-
oped and validated considering the requirements of ICH. The
proposed method permits the determination of PHMB in
liquid and gel-like preparations with excellent results. In
addition, the performance of the analytical method has been
veriﬁed for application to routine analysis in quality control
and assessment of stability.
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